SG/PUT/AMGEN/160/0.1/20.09.24 | Delayed Deutsche Boerse AG 01:22:37 03/07/2024 pm IST | ||
| 0.001 EUR | 0.00% |
|
| 6 months | -98.98% | ||
| Current year | -98.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.001 | 0.00% |
| 02/24/02 | 0.001 | 0.00% |
| 01/24/01 | 0.001 | 0.00% |
| 28/24/28 | 0.001 | 0.00% |
| 27/24/27 | 0.001 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update July 03, 2024 at 01:22 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SV6QSR |
| ISIN | DE000SV6QSR1 |
| Date issued | 24/05/2023 |
| Strike | 160 $ |
| Maturity | 20/09/2024 (80 Days) |
| Parity | 10 : 1 |
| Emission price | 0.62 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.71 € |
|---|---|
| Lowest since issue | 0.001 € |
| Spread | 0.055 € |
| Spread % | 98.21% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.82%
- Stock Market
- Warrants
- Warrant
